Kineta Announces Participation at October Investor Conferences
SEATTLE, Sept. 28, 2023 -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resist ...